These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25142475)

  • 1. Imaging cardiac sarcoidosis by cardiac positron emission tomography (PET): a local experience using a high-fat, low-to-no carbohydrate protocol.
    Koh AS; Kok TY; Sim DK; Lath N; Tan RS
    Ann Acad Med Singap; 2014 Jul; 43(7):383-5. PubMed ID: 25142475
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppressing physiologic 18-fluorodeoxyglucose uptake in patients undergoing positron emission tomography for cardiac sarcoidosis: The effect of a structured patient preparation protocol.
    Christopoulos G; Jouni H; Acharya GA; Blauwet LA; Kapa S; Bois J; Chareonthaitawee P; Rodriguez-Porcel MG
    J Nucl Cardiol; 2021 Apr; 28(2):661-671. PubMed ID: 31111450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of Myocardial 18F-FDG Uptake Through Prolonged High-Fat, High-Protein, and Very-Low-Carbohydrate Diet Before FDG-PET/CT for Evaluation of Patients With Suspected Cardiac Sarcoidosis.
    Lu Y; Grant C; Xie K; Sweiss NJ
    Clin Nucl Med; 2017 Feb; 42(2):88-94. PubMed ID: 27922863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Multi-modality Cardiac Imaging Approach to Cardiac Sarcoidosis.
    Ricci F; Mantini C; Grigoratos C; Bianco F; Bucciarelli V; Tana C; Mastrodicasa D; Caulo M; Donato Aquaro G; Raffaele Cotroneo A; Gallina S
    Curr Med Imaging Rev; 2019; 15(1):10-20. PubMed ID: 31964322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis.
    Ohira H; Birnie DH; Pena E; Bernick J; Mc Ardle B; Leung E; Wells GA; Yoshinaga K; Tsujino I; Sato T; Manabe O; Oyama-Manabe N; Nishimura M; Tamaki N; Dick A; Dennie C; Klein R; Renaud J; deKemp RA; Ruddy TD; Chow BJW; Davies R; Hessian R; Liu P; Beanlands RSB; Nery PB
    Eur J Nucl Med Mol Imaging; 2016 Feb; 43(2):259-269. PubMed ID: 26359191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of F18-fluorodeoxyglucose positron emission tomography in identifying patients at high risk for lethal arrhythmias from cardiac sarcoidosis and the use of serial scanning to guide therapy.
    Paz YE; Bokhari S
    Int J Cardiovasc Imaging; 2014 Feb; 30(2):431-8. PubMed ID: 24293048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (18)F-FDG PET/CT for the assessment of myocardial sarcoidosis.
    Skali H; Schulman AR; Dorbala S
    Curr Cardiol Rep; 2013 May; 15(5):352. PubMed ID: 23504346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG PET/CT for the assessment of myocardial sarcoidosis.
    Skali H; Schulman AR; Dorbala S
    Curr Cardiol Rep; 2013 Apr; 15(4):352. PubMed ID: 23544184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient page-sarcoidosis imaging.
    Bois JP; Chareonthaitawee P
    J Nucl Cardiol; 2019 Feb; 26(1):222-226. PubMed ID: 29094295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Right ventricular mass: a rare presentation of cardiac sarcoidosis.
    Bertic M; Tandon S; Wisenberg G
    Eur Heart J; 2016 Mar; 37(11):859. PubMed ID: 26705387
    [No Abstract]   [Full Text] [Related]  

  • 11. Complete resolution of focal-on-diffuse myocardial activity pattern on FDG PET-CT by prolonging the dietary preparation protocol in cardiac sarcoidosis.
    Kherajani P; Farag AA; Morgan WS; Hage FG; Bhambhvani P
    J Nucl Cardiol; 2023 Dec; 30(6):2525-2530. PubMed ID: 37524998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by ¹⁸F- fluorodoexyglucose positron emission tomography?
    Mc Ardle BA; Birnie DH; Klein R; de Kemp RA; Leung E; Renaud J; DaSilva J; Wells GA; Beanlands RS; Nery PB
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):617-26. PubMed ID: 23884290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis.
    Soussan M; Brillet PY; Nunes H; Pop G; Ouvrier MJ; Naggara N; Valeyre D; Weinmann P
    J Nucl Cardiol; 2013 Feb; 20(1):120-7. PubMed ID: 23188627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations.
    Ishida Y; Yoshinaga K; Miyagawa M; Moroi M; Kondoh C; Kiso K; Kumita S
    Ann Nucl Med; 2014 May; 28(4):393-403. PubMed ID: 24464391
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of heparin loading during an 18F-FDG PET/CT examination to search for cardiac sarcoidosis activity.
    Ito K; Morooka M; Okazaki O; Minaminoto R; Kubota K; Hiroe M
    Clin Nucl Med; 2013 Feb; 38(2):128-30. PubMed ID: 23334129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of positron emission tomography in the assessment of cardiac sarcoidosis.
    Genovesi D; Bauckneht M; Altini C; Popescu CE; Ferro P; Monaco L; Borra A; Ferrari C; Caobelli F
    Br J Radiol; 2019 Aug; 92(1100):20190247. PubMed ID: 31166768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac FDG/PET imaging mimicking sarcoidosis.
    Lai JKC; Teo E; Lichtenstein M; Toh HB; Sivaratnam D
    J Nucl Cardiol; 2019 Jun; 26(3):1025-1027. PubMed ID: 30627883
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection of cardiac sarcoidosis by macrophage-directed somatostatin receptor 2-based positron emission tomography/computed tomography.
    Reiter T; Werner RA; Bauer WR; Lapa C
    Eur Heart J; 2015 Sep; 36(35):2404. PubMed ID: 26093640
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cardiac sarcoidosis detected by FDG-PET].
    Goto K; Okamoto E; Morita M; Sasamoto T; Endo M; Umezawa K; Suguta M; Kaneko Y; Nakano A; Arai M; Hasegawa A; Kurabayashi M
    Nihon Naika Gakkai Zasshi; 2005 Jul; 94(7):1396-8. PubMed ID: 16097596
    [No Abstract]   [Full Text] [Related]  

  • 20. Fasting FDG PET compared to MPI SPECT in cardiac sarcoidosis.
    Brancato SC; Arrighi JA
    J Nucl Cardiol; 2011 Apr; 18(2):371-4. PubMed ID: 21318450
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.